Attached files

file filename
EX-21.1 - EXHIBIT 21.1 - IMMUNE PHARMACEUTICALS INCc14837exv21w1.htm
EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INCc14837exv31w2.htm
EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INCc14837exv32w1.htm
EX-23.1 - EXHIBIT 23.1 - IMMUNE PHARMACEUTICALS INCc14837exv23w1.htm
EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INCc14837exv31w1.htm
10-K - FORM 10-K - IMMUNE PHARMACEUTICALS INCc14837e10vk.htm
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
The undersigned is the Chief Financial Officer of EpiCept Corporation (the “Issuer”). This certification is made pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This certification accompanies the Annual Report on Form 10-K of the Issuer for the annual period ended December 31, 2010.
I, Robert W. Cook, certify that the Annual Report on Form 10-K for the period ended December 31, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that information contained in the Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.
Date: March 31, 2011
     
/s/ Robert W. Cook
   
 
Robert W. Cook
   
Senior Vice President and Chief Financial Officer